The reason VIP Dx/UNEVX can't continue to use the same test for XMRV/HGRV, no matter what they call it, is because WPI was unable to validate the VIP Dx test. One point I want to emphasize is that it is VIP Dx's test results that are in question here, not the research results upon which WPI relied in its research publications. The problem with the VIP tests would not affect the results of tests used in research at WPI because WPI researchers used several tests on each sample, and VIPDx used totally different tests and sample matrices that were never validated against WPI methods or done with the appropriate controls. Dr. Judy Mikovits was not part of VIP Dx, and she is not part of UNEVX either, as far as I know. Whatever problems VIP Dx has, they are theirs and not WPI'S.